Dr. Raymond Woosley is vice president of health sciences and a professor of pharmacology at the University of Arizona, Tucson.

FORBES: Pharmaceuticals

Woosley suggests that if trials were run by the government, fewer safeguards would be needed to make sure they are done honestly, actually decreasing cost.

FORBES: Magazine Article

"We need to ensure there is a benefit, not a liability, that we are giving to those seniors, " says Raymond Woosley , vice president for health sciences at the University of Arizona.

FORBES: FDA Fix No. 4: Government-Funded Studies

While at Georgetown, Woosley did work that led him to believe that Chlor-Trimetron, an old Schering-Plough (nyse: SGP - news - people ) drug, might be much more effective and less sedating than had been previously believed.

FORBES: Pharmaceuticals

One solution, proposed by Raymond Woosley, the Vice President for Health Sciences at the University of Arizona, is to carefully track the first 100, 000 patients who take a drug in order to look for higher rates of common health problems.

FORBES: FDA Fix No. 3: Track Side Effects

For instance, Raymond Woosley , vice president of health research at the University of Arizona and a noted pharmacologist, has said that the antihistamine Chlor-Trimetron was originally approved not based on a clinical trial, but by a survey of doctors.

FORBES: Why Cheap, Effective Drugs Go Unused

"I think the drug companies are going to do some big, expensive trials, but until they're done with real objectivity, I worry, " says Raymond Woosley , vice president of health sciences at the University of Arizona and a noted drug-safety expert.

FORBES: The Heavy Weight Of Clinical Trials